Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining -0.33% today. In the last week its performance is -2.25%, and 20.22% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 341.79, so today’s gain of -0.33% is a significant step towards its target price. The GAP today is therefore 0.79%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 66830.09, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.50%.
At the current price of 304.59, it has a dividend yield of *TBA, and its target price is 341.79. This is with a profit margin of 34.00%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 17.78, as well as a forward P/E of 14.63.
With a current EPS of 17.13, and a forecasted EPS growth for next year at 3.74%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 8.57%.
Performance for the year is 13.16%. Since its IPO date on 9/17/1991, the total performance to date is -0.57%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 976500, while its average volume is 1688.69. Whilst the total gain today was -0.33%, it did have a day high of -8.71%.
Volatility for this week has been at 1.64%, and 1.98% for the month. The 52-week low for Biogen Inc., BIIB has been 36.58%, while the 52-week-high has reached -8.71%.
Looking at its return of investments, which is 23.50%, and its return on assets is 18.50%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.90%. With a sales growth of 11.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 3 and 2.6 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.07, and the P/S is 5.95, along with a P/B of 5.85. Meanwhile it has a p/cash of 17.6.